-
FluGen, Bharat Biotech and UW–Madison partner on Covid-19 vaccine
pharmaceutical-technology
April 06, 2020
Vaccine development companies FluGen and Bharat Biotech have partnered with the University of Wisconsin–Madison (UWMadison) to develop and evaluate a Covid-19 vaccine candidate, CoroFlu.
-
Thermo Fisher Scientific to enhance capacity for COVID-19 testing in India
expresspharma
April 06, 2020
Thermo Fisher Scientific announced that it is accelerating its efforts with diagnostic testing and vaccine development technologies to effectively manage COVID-19 outbreak in the country.
-
Johnson & Johnson Announces Lead Vaccine Candidate for COVID-19, Partners with HHS
americanpharmaceuticalreview
April 03, 2020
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020.
-
Israeli scientists begin animal testing of Covid-19 vaccine prototype
pharmaceutical-technology
April 03, 2020
The Israel Institute for Biological Research (IIBR) has made ‘significant’ progress in creating a Covid-19 vaccine prototype and preparations are underway for animal testing, said Prime Minister Benjamin Netanyahu.
-
Australia’s CSIRO starts first stage of coronavirus vaccine testing
pharmaceutical-technology
April 03, 2020
The Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Australia has begun the first stage of testing of two potential Covid-19 vaccines.
-
FDA and EMA offer updates on COVID-19 treatments and vaccines in development
europeanpharmaceuticalreview
April 02, 2020
The FDA and EMA have announced which COVID-19 treatments and vaccines are currently in development, as well as how they are supporting clinical trials.
-
VBI Vaccines to develop pan-coronavirus vaccine
pharmaceutical-technology
April 02, 2020
VBI Vaccines has partnered with the National Research Council of Canada (NRC) to create a pan-coronavirus vaccine candidate.
-
US HHS expedites development and manufacture of Covid-19 vaccines
pharmaceutical-technology
April 01, 2020
The US Department of Health and Human Services (HHS) is accelerating the development and manufacture of vaccines against the Covid-19 coronavirus infection.
-
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
expresspharma
April 01, 2020
The company will also establish a new US Vaccine manufacturing capabilities and additional production capacity outside the US to begin production at risk to help ensure global vaccine supply.
-
COVID-19: NICE updates guideline as Sanofi announces vaccine development
pharmatimes
March 31, 2020
As the number of deaths in the UK more than doubled over the weekend, The National Institute for Health and Care Excellence (NICE) has updated its rapid COVID-19 critical care guideline.